Navigating U.S. Biotech Hubs, Sector Strengths and IP Strategy
This web seminar is part of our international “Biotech Goes Global” series, supporting Bavarian biotech companies in accessing key global markets. This edition places the spotlight on the United States – a highly dynamic life sciences environment characterised by world‑leading research hubs, global pharmaceutical players, a strong venture ecosystem, and distinct collaboration cultures.
Join us to explore how Bavarian and European life sciences companies can strategically engage with U.S. biotech hubs, identify relevant sector opportunities, and understand critical success factors when entering or operating in the U.S. market.
This session addresses key considerations for companies in the health sector (including biotechnology, pharmaceuticals, medical technology, and digital health) that are interested in gaining a better understanding of the U.S. life sciences landscape.
The webinar combines ecosystem insights with practical perspectives on sector focus and intellectual property, and is particularly valuable for companies planning international expansion, partnerships, or participation in Bio International and other U.S. conferences.
In this session, you will:
- gain an overview of leading U.S. biotech hubs and their distinctive innovation ecosystems
- learn about flagship sectors and therapeutic strengths (such as oncology or regenerative medicine) and where current opportunities lie
- understand the role of accelerators and innovation programmes in facilitating market entry and collaboration
- receive practical insights into IP strategy, why it is critical when operating in the U.S. market, and how it impacts long‑term venture success
